Skip to main content
Premium Trial:

Request an Annual Quote

Jim Wright, Aiping Young

Premium
Antisense drug developer Lorus Therapeutics said this week that President and CEO Jim Wright has resigned.
 
According to the company, Wright will continue to be associated with Lorus as a director and special advisor.
 
Lorus also announced that Aiping Young has been appointed the firm’s new president and CEO.
 
Young has held a number of positions at Lorus, including vice president of research and development, CTO, and COO. Most recently, he was vice president of research for Lorus subsidiary GeneSense Technologies.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.